- Posted May 13, 2014 by
- Consumers Increasingly Becoming Concerned with Food Packaging Safety
- Seniors’ Narcotics Use Under Medicare is a Growing Concern – Report
- Growing Global Population Driving Force Behind Food Industry Mergers
- Pacific Shore Holdings, Inc. Aims to Become a Billion Company Within 5 Years in Green Scene Products Arena
- 52% More Restaurants to Offer Gluten-Free Dishes in 2014 – survey
Missouri Remains Lone State Without Prescription Drug Database
KCUR.org, in a report, said Missouri may remain the only state without prescription drug monitoring because of the opposition.
Republican Representative Kevin Engler of Farmington is sponsoring House Bill 1133, which will create a database through the information that pharmacists will give to the Department of Health and Senior Services. It is the department that will notify law enforcement if signs of abuse are noticed. While pharmacists, doctors and regulatory groups will have access to the information, law enforcers will need a court order to do the same.
However, people like Republican Senator Rob Schaaf of St. Joseph pointed out that is giving too much information into the hands of other people.
He said “hundreds” of his constituents are asking him to protect their privacy.
Engler, although sympathetic to concerns of privacy advocates, said the information is already in the hands of insurance companies.
He said that while data breach is a “possibility,” death due to drug abuse is a reality.
Interestingly, Schaaf has put forward his own version of a drug database bill but Missouri Pharmacy Association chief executive Ron Fitzwater said the version is not enough to reduce abuse.
Nevertheless, he said it was a good start since there is “open dialog.”
Engler, on the other hand, said it is only Schaaf’s way of saving face.
The drug database bill in 2012 failed in the Senate after Schaaf filibustered it, saying it violated the citizens’ rights.
Advocates of the bill argue d that there is a pressing need for the bill, especially since a report by Trust of America’s Health revealed that drug overdoses in Missouri tripled between 1999 and 2010. The non-profit organization added that Missouri is the top seven among the states with the highest drug overdose mortality rate.
It is not surprising that treatment companies like BioCorRx Inc. (BICX, http://finance.yahoo.com/q?s=BICX) have been targeting Missouri as a new venue for their programs’ expansion.
Last March, BioCorRx entered into a letter of intent to sell the exclusive license and distribution rights of its Start Fresh Program in Minnesota, Missouri and Oklahoma to Fresh Start Private Midwest, LLC.
The company said it was not only an opportunity to make their program a national household brand but also to benefit patients in the said states. In Missouri alone, impaired driving deaths cost taxpayers $1.4 billion per year.
BioCorRx’s Start Fresh Program not only addresses dependence on prescription drugs but also alcoholism. Their unique medication implant is made from naltrexone, an old drug that has been approved by the Food and Drug Administration (FDA) for the treatment of both drug and alcohol addiction for decades.
The medication is able to block parts of the brain that feels pleasure or euphoria upon the intake of prescription drugs and alcohol. With the cravings of patients placed under control in most cases, the program coaches are able to put the patients through life coaching sessions that allow them to plan for their future.